BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Trichostatin A
,
rs2476601
,
GATA1
,
glucose metabolic process
,
Obesity
,
Adipose tissue
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Serine/threonine-protein kinase, C-terminal
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal brain
Accumbens
Putamen
Caudate
Cerebellum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Chronic fatigue syndrome
Alpha-1-antitrypsin deficiency
Injury of eye region
Disease due to Orthopoxvirus
Disorder of digestive system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
ciprofibrate
1-azakenpaullone
Lipids
Benzodiazepinones
trinitrophenyl-bovine serum albumin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
LGR6
ULK2
ULK1
RPS20
FRG1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
RAW 264.7 macrophages treated with IFNγ, LPS, or 2-MA
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
Thyroid hormone mediated gene expression in the liver of juvinile mice
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Serine/threonine-protein kinase, C-terminal
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutat…
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Ho…
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid…
Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ